2 reports

  • Stemina Biomarker Discovery Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
  • May 10, 2016: Stemina Biomarker Discovery Announces Rebranding of Its Diagnostics Business, New Board Member Kevin Krenitsky, MD, and Progress from Its Clinical Study

To raise this finance, the company issued debt securities, option, warrant or other right to acquire another security to one investor.

  • Biomarker Discovery
  • Genomics
  • United States
  • Deals & Alliance
  • Stemina Biomarker Discovery, Inc.

It focuses in the areas of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity.

  • Biomarker
  • Biomarker Discovery
  • United States
  • Company
  • Stemina Biomarker Discovery, Inc.